1. Home
  2. ARQT vs GIC Comparison

ARQT vs GIC Comparison

Compare ARQT & GIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • GIC
  • Stock Information
  • Founded
  • ARQT 2016
  • GIC 1949
  • Country
  • ARQT United States
  • GIC United States
  • Employees
  • ARQT N/A
  • GIC N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • GIC Industrial Machinery/Components
  • Sector
  • ARQT Health Care
  • GIC Industrials
  • Exchange
  • ARQT Nasdaq
  • GIC Nasdaq
  • Market Cap
  • ARQT 1.1B
  • GIC 1.1B
  • IPO Year
  • ARQT 2020
  • GIC 1995
  • Fundamental
  • Price
  • ARQT $13.08
  • GIC $24.10
  • Analyst Decision
  • ARQT Strong Buy
  • GIC
  • Analyst Count
  • ARQT 5
  • GIC 0
  • Target Price
  • ARQT $17.00
  • GIC N/A
  • AVG Volume (30 Days)
  • ARQT 1.9M
  • GIC 114.0K
  • Earning Date
  • ARQT 02-25-2025
  • GIC 02-27-2025
  • Dividend Yield
  • ARQT N/A
  • GIC 4.14%
  • EPS Growth
  • ARQT N/A
  • GIC N/A
  • EPS
  • ARQT N/A
  • GIC 1.71
  • Revenue
  • ARQT $138,708,000.00
  • GIC $1,333,700,000.00
  • Revenue This Year
  • ARQT $215.24
  • GIC $4.61
  • Revenue Next Year
  • ARQT $53.63
  • GIC $3.15
  • P/E Ratio
  • ARQT N/A
  • GIC $14.23
  • Revenue Growth
  • ARQT 182.84
  • GIC 9.80
  • 52 Week Low
  • ARQT $5.38
  • GIC $23.09
  • 52 Week High
  • ARQT $16.20
  • GIC $46.97
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 41.94
  • GIC 36.82
  • Support Level
  • ARQT $13.33
  • GIC $24.78
  • Resistance Level
  • ARQT $15.09
  • GIC $25.86
  • Average True Range (ATR)
  • ARQT 0.86
  • GIC 0.50
  • MACD
  • ARQT -0.16
  • GIC 0.07
  • Stochastic Oscillator
  • ARQT 6.25
  • GIC 8.20

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About GIC Global Industrial Company

Global Industrial Co is a value-added industrial distributor. It distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials.

Share on Social Networks: